Appointment booking for Dr. David Chansolme, MD is currently not available.Dr. David Chansolme, MD has not yet fully activated their profile on DiabetesIQ.
Dr. David Chansolme, MD (he/him) is a Infectious Disease Doctor in Oklahoma City, OK with over 19 years of experience. What is your opinion of Dr. David Chansolme, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. David Chansolme, MD has received over $9,561 which includes payments from the following companies:
$6,697.15 from Astellas Pharma US Inc
$1,140.88 from The Medicines Company
$734.74 from ViiV Healthcare Company
$355.01 from Gilead Sciences Inc
$103.60 from Bard Access Systems, Inc.
$99.00 from Janssen Products, LP
$94.01 from Allergan Inc.
$90.52 from Melinta Therapeutics, Inc.
$77.12 from AbbVie, Inc.
$71.85 from Janssen Biotech, Inc.
$50.25 from Actavis Pharma Inc
$19.14 from Merck Sharp & Dohme Corporation
$14.83 from La Jolla Pharmaceutical Company
$13.45 from Biotest Pharmaceuticals Corporation
Payments received by Dr. David Chansolme, MD were from the following categories:
$6,500.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!